Cet anticorps anti-FGF17 Polyclonal Lapin (ABIN7220518) détecte spécifiquement FGF17 dans WB et ELISA.
L’anticorps est réactif avec des échantillons de Humain, Souris et Rat.
FGF17
Reactivité: Humain
WB, ELISA, Neut
Hôte: Lapin
Polyclonal
Biotin
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,ELISA 1:5000,Not yet tested in other applications.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
FGF17
(Fibroblast Growth Factor 17 (FGF17))
Autre désignation
FGF-13
Sujet
FGF13, FHF2, Fibroblast growth factor 13, FGF-13, Fibroblast growth factor homologous factor 2, FHF-2The fibroblast growth factor 13 encoded by FGF13 is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located in a region on chromosome X, which is associated with Borjeson-Forssman-Lehmann syndrome (BFLS), making it a possible candidate gene for familial cases of the BFLS, and for other syndromal and nonspecific forms of X-linked mental retardation mapping to this region. Alternative splicing of this gene at the 5' end results in several transcript variants encoding different isoforms with different N-termini.